Share the post "Godavari Drugs ‘s Q1 Report: Revenue Falls by 9.07% YoY"
Highlights
- The presented financial data is Standalone to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company’s sales declined by -9.07 % over the year, decrease in net sales/revenue by -16.65 %.
- Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 69.25 %. Marginal increase in other income during this quarter, up by 856.25%.
- Profit over the Year and quarter: Significant improvement in profitability for Godavari Drugs Ltd.. Notable increase of 101.36 % in net profit Year to Year, Godavari Drugs Ltd.’s profitability dropped by -38.73 % Quarter to Quarter.
- EPS over the Year and quarter: EPS increased by 100.93 % Year to Year. EPS decreased by -38.53 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 35.419 Cr | Rs. 38.64 Cr | Rs. 32.208 Cr | -16.65 % | -9.07 % |
| Expenses | Rs. 33.17 Cr | Rs. 34.17 Cr | Rs. 28.97 Cr | -15.22 % | -12.66 % |
| Operating Profit | Rs. 2.25 Cr | Rs. 4.47 Cr | Rs. 3.24 Cr | -27.52 % | + 44 % |
| OPM % | 6.35 % | 11.57 % | 10.06 % | -1.51 % | + 3.71 % |
| Other Income | Rs. 0.452 Cr | Rs. 0.08 Cr | Rs. 0.765 Cr | + 856.25 % | + 69.25 % |
| Interest | Rs. 1.11 Cr | Rs. 1.23 Cr | Rs. 1.44 Cr | + 17.07 % | + 29.73 % |
| Depreciation | Rs. 0.47 Cr | Rs. 0.53 Cr | Rs. 0.55 Cr | + 3.77 % | + 17.02 % |
| Profit before tax | Rs. 1.12 Cr | Rs. 2.79 Cr | Rs. 2.02 Cr | -27.6 % | + 80.36 % |
| Tax % | 27.48 % | 4.55 % | 18.94 % | + 14.39 % | -8.54 % |
| Net Profit | Rs. 0.81 Cr | Rs. 2.66 Cr | Rs. 1.63 Cr | -38.72 % | + 101.23 % |
| EPS in Rs | Rs. 1.08 | Rs. 3.53 | Rs. 2.17 | -38.53 % | + 100.93 % |
Today, we’re looking at Godavari Drugs Ltd.’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a significant year-over-year sales decline of -9.07 %. However, it did see a marginal slip of -16.65 % from the previous quarter. Expenses decreased slightly by -15.22 % quarter-on-quarter, aligning with the annual decline of -12.66 %. Operating profit, while up 44 % compared to last year, faced a quarter-on-quarter dip of -27.52 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 3.71 %, but a shrinkage of -1.51 % sequentially. Other income rose by 856.25 % compared to the last quarter, despite an annual growth of 69.25 %. Interest expenses surged remarkably by 17.07 % from the previous quarter, yet the year-over-year increase remains at a moderate 29.73 %. Depreciation costs climbed by 3.77 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 17.02 %. Profit before tax grew annually by 80.36 % but saw a reduction from the preceding quarter by -27.6 %.
Tax expenses as a percentage of profits decreased slightly by -8.54 % compared to last year, with a more notable quarter-on-quarter increase of 14.39 %. Net profit rose by 101.23 % year-on-year but witnessed a -38.72 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 100.93 % but a quarterly fall of -38.53 %. In summary, Godavari Drugs Ltd.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 35.419 Cr | Rs. 38.64 Cr | Rs. 32.208 Cr | -16.65 % | -9.07 % |
| Expenses | Rs. 33.17 Cr | Rs. 34.17 Cr | Rs. 28.97 Cr | -15.22 % | -12.66 % |
| Operating Profit | Rs. 2.25 Cr | Rs. 4.47 Cr | Rs. 3.24 Cr | -27.52 % | + 44 % |
| Net Profit | Rs. 0.81 Cr | Rs. 2.66 Cr | Rs. 1.63 Cr | -38.72 % | + 101.23 % |
| EPS in Rs | Rs. 1.08 | Rs. 3.53 | Rs. 2.17 | -38.53 % | + 100.93 % |
In reviewing Godavari Drugs Ltd.’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -9.07 % year-on-year, although there was a slight dip of -16.65 % from the previous quarter. Expenses decreased by -12.66 % compared to the previous year, with a decrease of -15.22 % quarter-on-quarter. Operating Profit surged by 44 % annually, and saw a -27.52 % decrease from the last quarter.
Net Profit showed yearly increase of 101.23 %, and experienced a -38.72 % decrease from the previous quarter. Earnings Per Share (EPS) rose by 100.93 % annually, however dipped by -38.53 % compared to the last quarter. In essence, while Godavari Drugs Ltd. exhibits strong annual growth indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.
[my_shortcode1]
